Pharmacological action

Combined antibacterial agent for topical application. Contains two antibiotics, which have a bactericidal effect, neomycin and bacitracin.

Bacitracin is a polypeptide antibiotic that inhibits the synthesis of the bacterial cell membrane. Bacitracin is particularly active against gram-positive microorganisms, such as β-hemolytic streptococci, staphylococci, and some gram-negative pathogens. Resistance to bacitracin is extremely rare.

Neomycin is an antibiotic-aminoglycoside, which inhibits the synthesis of bacterial proteins. It is active against gram-positive and gram-negative bacteria.

By using a combination of these two antibiotics, a broad spectrum of action of the drug is achieved and synergism of action against a number of microorganisms, for example, staphylococci.

Indications

Baneocin® powder is indicated for use in infections caused by microorganisms sensitive to neomycin and / or bacitracin:

- bacterial skin infections of limited prevalence, for example, wetting contagious impetigo, infected trophic ulcers of the lower extremities, infected eczema, bacterial diaper dermatitis, bacterial complications of viral infections caused by Herpes simplex or Herpes zoster (including infection of vesicles with chicken pox);

- prevention of umbilical infection in newborns;

- prevention of infection after surgical (dermatological) procedures: for additional treatment in the postoperative period (after excision of tissues, cauterization, episiotomy, treatment of cracks, rupture of perineum, wiping wounds and sutures).